Andrew P. Smith, Chief Financial Officer at Sucampo Pharmaceuticals, Inc. (SCMP), bought 1,605 shares at $17.03 ($27K) on 2015-11-16, disclosed to the SEC on 2015-11-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.